Vomiting appeared slightly more frequent in the vaccine group, but the difference did not reach statistical significance and the overall numbers proved low (12 versus 4 cases); monitoring is also warranted in future studies.
← all excerpts
Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.
1
—
—